Central India Chronicle

Onychosis Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies – Veloce Biopharmaceuticals, Blueberry Therapeutics, Pfizer, Galderma, Moberg Biophar

 Breaking News
  • No posts were found

Onychosis Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies – Veloce Biopharmaceuticals, Blueberry Therapeutics, Pfizer, Galderma, Moberg Biophar

May 23
22:25 2023
Onychosis Market is Expected to Expand at a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - Veloce Biopharmaceuticals, Blueberry Therapeutics, Pfizer, Galderma, Moberg Biophar
DelveInsight Business Research LLP
DelveInsight’s “Onycholysis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Onycholysis, historical and forecasted epidemiology as well as the Onycholysis market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s Onycholysis Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of the Onycholysis, epidemiology insights, Onycholysis market trends, therapies, and key companies working in the Onycholysis Market in the 7MM.

Onychosis  Overview

Onycholysis is a common medical condition characterized by the painless detachment of the nail from the nail bed, usually starting at the tip and sides. On the hands, it occurs mainly on the ring finger but can appear on any fingernail. It may also happen to toenails. Onycholysis can occur in many conditions, including psoriasis. In thyrotoxicosis, it is thought to be due to sympathetic overactivity. It may also be seen in infections or trauma.

 

Onychosis Epidemiology Insights

  • A retrospective study was carried out from 01/01/2015 to 31/12/2017 based on files of patients who visited the outpatient clinic of the hospital “Andreas Syggros” (Athens, Greece) with clinical signs of possible onychomycosis. The study protocol was approved by the ethics committee of the hospital.

  • There were 3,548 visits recorded during this period. After excluding patients with multiple stops, there remained 3,226 adult patients (904 men and 2,322 women) who were evaluated for possible onychomycosis.

Click here to learn more about the Onychosis Market Landscape

The Report Covers the Onychosis  Epidemiology Segmented by:

  • Total Onychosis incident cases 

  • Total Onychosis prevalent cases 

  • Total Onychosis treatment cases 

  • Total Onychosis diagnostic cases 

Onychosis Market Outlook 

The Onycholysis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Onycholysis market trends by analyzing the impact of current Onycholysis therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Onycholysis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Onycholysis market data are presented with relevant tables and graphs to give a clear picture of the market at first sight.

According to DelveInsight, the Onycholysis market in 7MM is expected to change in the study period 2019-2032.

Key Companies Working in the Onychosis Market

  • Veloce Biopharmaceuticals 

  • Blueberry Therapeutics 

  • Pfizer 

  • Galderma 

  • Moberg Biopharmaceuticals 

And many others 

Onychosis Therapies Covered and Analyzed in the Report:

  • VBP-926

  • Amorolfine

  • BB2603-1

  • Ciclopirox

  • Albaconozole

And many others 

Learn more about the Key Companies and Emerging Therapies in the Onychosis Market

 Table of Contents 

  1. Key Insights 

  2. Onychosis  Introduction 

  3. Executive Summary of Onychosis   

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Onychosis Emerging Therapies

  7. Onychosis Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Learn about the detailed offerings of the report @ Onychosis Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services